Manufacturing, Biologic Drugs

Enable Injections Completes its High-Volume Injector Manufacturing Facility

June 07, 2016

The wearable devices for the delivery of biologic products are now being manufactured and will be tested in clinical trials in the near future, according to the company.

Building a Better Self-Injection Solution

June 02, 2016

Experts discuss the key considerations in the development of an autoinjector.

Lessons Learned Accelerate Vaccine Development

May 15, 2016

Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing

MilliporeSigma Expands California GMP Facility

May 04, 2016

MilliporeSigma expands its Carlsbad, California-based GMP capacity for viral and gene-therapy products by nearly 90%.

Sanofi Invests €300 Million in Biologics Manufacturing Facility

April 19, 2016

Sanofi will invest in its Geel, Belgium facility in order to support its pipeline of monoclonal antibodies.

Report Examines Price Increases on Most Widely Used Drugs in US

April 08, 2016

A report by Reuters found that four of the top 10 most widely used drugs increased 100% since 2011, while the other six increased 60%.

Vaccine Development Faces Urgency and Challenges

April 02, 2016

Global outbreaks energize vaccine R&D and drive production modernization.

Novo Nordisk Builds Manufacturing Facility in North Carolina

March 29, 2016

Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.

Designing a Biomanufacturing Facility Incorporating Single-Use Technologies

March 02, 2016

Asking the right questions is crucial to establishing a biopharmaceutical facility design.

Takeda Acquires US Biologics Manufacturing Facility

January 06, 2016

Takeda Pharmaceuticals announced the acquisition of a biopharmaceuticals manufacturing plant in Minnesota.